{"transactions":[{"id":931305,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":68806,"kind":"person","name":"Markus Richard","position":1,"cik":"0002056093","reported_name":"Markus Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-26T20:21:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable in 48 equal monthly installments after January 1, 2026, subject to the Reporting Person's continued service to the Company."}],"balance_after":96000,"derivative":{"exercise_price":22.13,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0002056093-26-000002","document":"wk-form4_1769476911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056093/000205609326000002/wk-form4_1769476911.xml","form_type":"4"}},{"id":931304,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":68806,"kind":"person","name":"Markus Richard","position":1,"cik":"0002056093","reported_name":"Markus Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-26T20:21:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2026, subject to the Reporting Person's continued service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the unvested portion of the Reporting Person's RSU grants."}],"balance_after":89647,"source":{"system":"sec-edgar","filing":"0002056093-26-000002","document":"wk-form4_1769476911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056093/000205609326000002/wk-form4_1769476911.xml","form_type":"4"}},{"id":963408,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":68806,"kind":"person","name":"Markus Richard","position":1,"cik":"0002056093","reported_name":"Markus Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-18T17:35:37.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":4494,"price":22.1595,"value":99584.793,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the\ndate of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting\nperson."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the unvested portion of the reporting person's RSU grants."}],"balance_after":65647,"source":{"system":"sec-edgar","filing":"0002056093-25-000005","document":"wk-form4_1766097334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056093/000205609325000005/wk-form4_1766097334.xml","form_type":"4"}},{"id":963407,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":68806,"kind":"person","name":"Markus Richard","position":1,"cik":"0002056093","reported_name":"Markus Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-18T17:35:37.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":5052,"price":21.8843,"value":110559.4836,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the\ndate of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting\nperson."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes the unvested portion of the reporting person's RSU grants."}],"balance_after":70141,"source":{"system":"sec-edgar","filing":"0002056093-25-000005","document":"wk-form4_1766097334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056093/000205609325000005/wk-form4_1766097334.xml","form_type":"4"}},{"id":1274349,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":68806,"kind":"person","name":"Markus Richard","position":1,"cik":"0002056093","reported_name":"Markus Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-11T21:10:58.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":305328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in 48 equal monthly installments after February 1, 2025, subject to the Reporting Person's continued service to the Company"}],"balance_after":305328,"derivative":{"exercise_price":12.45,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":305328},"source":{"system":"sec-edgar","filing":"0001724521-25-000032","document":"wk-form4_1739326250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056093/000172452125000032/wk-form4_1739326250.xml","form_type":"4"}},{"id":1274348,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":68806,"kind":"person","name":"Markus Richard","position":1,"cik":"0002056093","reported_name":"Markus Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-11T21:10:58.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":75193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in four equal annual installments beginning March 15, 2026, subject to the Reporting Person's continued service to the Company."}],"balance_after":75193,"source":{"system":"sec-edgar","filing":"0001724521-25-000032","document":"wk-form4_1739326250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056093/000172452125000032/wk-form4_1739326250.xml","form_type":"4"}}]}